Kelowna

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 22 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• GlaxoSmithKline2 trials
• Tesaro, Inc.1 trial

Running trials

• Active, not recruiting

  A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

  NCT06748053· Phase 2· GlaxoSmithKline· Source

• Recruiting

  A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

  NCT04641247· Phase 2· GlaxoSmithKline· Source

  Contact: Anna Tinker (principal investigator)

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting
• Prostate cancer1 recruiting